Logo
Pharmidex partners in European Commission H2020 award
May 21, 2017

Pharmidex joins Horizon 2020 EU project to work on radioactive contamination

Pharmidex partners in European Commission H2020 award

This project aims to stimulate intersectoral and international collaboration within Europe and with an ICPC country, Kazakhstan, in the area of novel nanoporous and nanostructured adsorbents for the treatment of very serious health conditions associated with acute and chronic exposure to external radiation and uptake of heavy metals and radiation as a consequence of accidental, occupational or deliberate activities and events.


This can dramatically lower the quality of life of the people affected and at present the treatment available is costly and inefficient. Radioactive contamination is a particularly serious problem in two of the countries participating in this project, namely, Ukraine and Kazakhstan, on large territories of the Chernobyl zone and around Semipalatinsk nuclear test site, respectively.


A large number of people are affected by living in the areas with elevated level of radioactivity with uncertain long-term consequences to their health and the health of future generations.


The expected impact of the project results is development of efficient and cost-effective methods of protection of first responders, population and cancer patients treated with radiotherapy from elevated doses of external and incorporated radiation and for occupational health protection of personnel working and the population living in areas contaminated with heavy metals.


Please find more information on the following web page: http://cordis.europa.eu/project/rcn/207057_en.html

February 18, 2025
We’re thrilled to offer Haematology Services to advance drug development and research. Our lab features, the Siemens analyser, delivering precise results across key biological parameters. 🔬 Services Include: Full Blood Count (FBC) Reticulocytes Differential Analysis 🐾 Supporting human and animal models 💡 Applications: Diagnose blood disorders (anaemia, leukaemia and others). Evaluate treatment efficacy in preclinical models. Translate findings from animals to humans. 📦 Sample Details: Minimum 200 µL of EDTA whole blood. Reach out today to learn how we can support your research!
February 13, 2025
We had great fun networking, supporting wellbeing, nurturing our community and raising money for Stevenage based STEMPOINT , the educational charity dedicated to widening access into science, engineering, maths and technology subjects across EastAnglia. Over 30 players took part in the cross-campus sports event, we welcomed teams from GSK, ImmuONE, Tessellate BIO, Neobe Therapeutics, Stevenage Bioscience Catalyst, Pharmidex , MFX, Antikor Biopharma Ltd – and of course STEMPOINT - who came to join us. Congratulations goes to Ash Alavijeh from Pharmidex who won best player of the rally! See you all again in the next badminton tournament in the Spring!
OBN Science Social
February 12, 2025
Pharmidex at OBN Science Social
More Posts
Share by: